Interim Dividend Timetable - Record Date
ALLIANCE PHARMA PLC
("Alliance" or the "Group")
In the announcement of its interim results for the six months ended 30 June 2015 on 9 September 2015, the Company announced that in relation to its interim dividend of 0.366 pence per share, the record date will be 21 December 2015.
The Company would like to clarify that the record date for its interim dividend will in fact be 18 December 2015 and not 21 December 2015. All other details relating to the Company's interim dividend remain as disclosed in the announcement on 9 September 2015.
For further information:
Alliance Pharma plc + 44 (0)1249 466966
Peter Butterfield, Chief Executive Officer
Andrew Franklin, Chief Financial Officer
Buchanan + 44 (0)20 7466 5000
Mark Court / Sophie Wills / Hannah Ratcliff
Numis Securities Limited + 44 (0)20 7260 1000
Nominated Adviser: Michael Meade / Freddie Barnfield
Corporate Broking: James Black
Investec Bank plc + 44 (0)20 7597 5970
Corporate Finance: Daniel Adams / Ed Thomas
Corporate Broking: Patrick Robb / Tejas Padalkar
Notes to editors:
About Alliance
Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.
Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.